Evidence map›Paper›PMID 41869035›Full record

ReviewFrontiers in endocrinology2026

Non-medical use of exogenous testosterone and anabolic-androgenic substances in young men: health, psychological, and fertility consequences.

Krzysztof Kowalik, Patryk Harasny, Laura Kaliczyńska, Konrad Reweda-Kwiatkowski, Dariusz Starzyński, Michał Pawlak, Arkadiusz Waloryszak, Magdalena Ptak, Andrzej Modrzejewski, Dagmara Lisman

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Krzysztof KowalikClinical Department of General Surgery, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Patryk HarasnyDepartment of Urology, Provincial Hospital, Poznań, Poland.
Laura KaliczyńskaUniversity of Szczecin, Szczecin, Poland.
Konrad Reweda-KwiatkowskiFaculty of Health Sciences, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Dariusz StarzyńskiEndocrinology Clinic, Sedimed Medical Centre, Szczecin, Poland.
Michał PawlakFaculty of Dentistry, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Arkadiusz WaloryszakClinical Department of General Surgery, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Magdalena PtakIndependent Unit of Perineological Physiotherapy, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Andrzej ModrzejewskiClinical Department of General Surgery, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Dagmara LismanDepartment of Genomics and Forensic Genetics, Pomeranian Medical University in Szczecin, Szczecin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The non-medical use of exogenous testosterone and other anabolic-androgenic steroids (AAS) has increased substantially in recent years, particularly among young men engaged in recreational strength training. Although often perceived as a means of enhancing muscle mass and physical performance, this practice represents a growing public-health concern due to its wide-ranging endocrine, reproductive, and multisystem adverse effects. This narrative review synthesizes current international evidence on the non-medical use of testosterone and AAS in non-professional athletic settings, with a primary focus on endocrine disruption and reproductive health. The review outlines the classification of commonly used anabolic-androgenic compounds, discusses their pharmacological mechanisms of action, and integrates clinical, experimental, and epidemiological data on associated adverse outcomes. Particular attention is given to suppression of the hypothalamic-pituitary-gonadal axis, impaired spermatogenesis, fertility disturbances, and the potential for long-term or persistent endocrine sequelae. In addition, psychological and behavioural factors contributing to AAS use-including muscle dysmorphia, social pressure, and body-image concerns-are discussed as important modulators of risk. The review also addresses current clinical approaches to the management of AAS-related complications, including strategies aimed at hormonal recovery and restoration of reproductive function. By presenting a comprehensive, mechanistic, and clinically oriented overview, this article highlights the need for increased awareness among clinicians and underscores priorities for future research and preventive interventions in endocrine and reproductive health.

Indexed as

Anabolic AgentsDoping in SportsFertilityInfertility, MaleTestosteroneAnabolic Androgenic SteroidsHumansHypothalamic-Pituitary-Gonadal AxisMaleAnabolic AgentsAnabolic Androgenic SteroidsTestosteroneanabolic–androgenic steroidsendocrine disruptionhypogonadismhypothalamic–pituitary–gonadal axismale infertilitytestosterone misuseyoung men

Identifiers

PMID41869035
PMCPMC12999365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.